Wells Fargo’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $64.1K | Sell |
|
|||||
|
2024
Q1 | $134K | Buy |
|
|||||
|
2023
Q4 | $68.8K | Buy |
|
|||||
|
2023
Q3 | $30.6K | Sell |
|
|||||
|
2023
Q2 | $76.3K | Buy |
|
|||||
|
2023
Q1 | $74.6K | Buy |
|
|||||
|
2022
Q4 | $138K | Sell |
|
|||||
|
2022
Q3 | $680K | Buy |
|
|||||
|
2022
Q2 | $157K | Sell |
|
|||||
|
2022
Q1 | $343K | Sell |
|
|||||
|
2021
Q4 | $587K | Sell |
|
|||||
|
2021
Q3 | $1.43M | Buy |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2021
Q1 | $1.89M | Buy |
|
|||||
|
2020
Q4 | $758K | Buy |
|
|||||
|
2020
Q3 | $349K | Buy |
|
|||||
|
2020
Q2 | $671K | Buy |
|
|||||
|
2020
Q1 | $216K | Buy |
|
|||||
|
2019
Q4 | $502K | Sell |
|
|||||
|
2019
Q3 | $455K | Buy |
|
|||||
|
2019
Q2 | $418K | Sell |
|
|||||
|
2019
Q1 | $251K | Sell |
|
|||||
|
2018
Q4 | $290K | Buy |
|
|||||
|
2018
Q3 | $539K | Buy |
|
|||||
|
2018
Q2 | $419K | Buy |
|
|||||
|
2018
Q1 | $206K | Buy |
|
|||||
|
2017
Q4 | $92K | Buy |
|
|||||
|
2017
Q3 | $14K | Buy |
|